Sartorius Accessia Pharma
0650.670.852 · rovalta.com · 24/09/2026
ACTIVE
Sartorius Accessia Pharma
Financial year 2025 · Closed on 31/12/2025
Net result
167,7 k €
+338,9 %over 1 yearRevenue
2,2 M €
+8,1 %over 1 yearEquity
-2 M €
+7,0 %over 1 yearWorkforce
4,8 ETP
-2,0 %over 1 yearOverview
Identity
Source · BCE/KBOSartorius Accessia Pharma is a Public limited company incorporated in 2016. Its main activity is: Rental and operating of own or leased real estate. Its registered office is in Herstal. It employs on average 4,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0650.670.852
- Incorporation
- 22/03/2016
- Legal form
- Public limited company
- Registered office
- Avenue du Parc Industriel 89
4041 Herstal · WallonieSee on map - Contributed capital
- 4 100 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 4,8 ETP
Activities (NACE)
68203Rental and operating of own or leased real estate· main68203Rental and operating of own or leased real estate77399Rental and leasing of other machinery, equipment and tangible goods n.e.c.77399Rental and leasing of other machinery, equipment and tangible goods n.e.c.68203Rental and operating of own or leased real estate68203Rental and operating of own or leased real estate+4
Joint committees (2)
- 200
- 323
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 10 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 2,2 M € | +8.1% | 2 M € | +73.9% | 1,2 M € | +37.3% | 854 k € | +17.3% | 727,9 k € |
| EBITDA | 997,7 k € | +17.0% | 852,9 k € | +1878% | 43,1 k € | +114% | -315,9 k € | +14.7% | -370,3 k € |
| Operating result | 507,3 k € | +31.3% | 386,3 k € | +197% | -397,3 k € | +48.5% | -770,9 k € | -4.0% | -741,1 k € |
| Net result | 167,7 k € | +339% | 38,2 k € | +106% | -683,2 k € | +35.0% | -1,1 M € | -24.2% | -846,1 k € |
| Balance sheet | |||||||||
| Equity | -2 M € | +7.0% | -2,1 M € | +0.9% | -2,1 M € | -49.2% | -1,4 M € | -150% | 2,8 M € |
| Total assets | 5,6 M € | -11.1% | 6,4 M € | -0.1% | 6,4 M € | -5.8% | 6,7 M € | -12.1% | 7,7 M € |
| Cash | 0 € | -100% | 2,4 k € | -83.3% | 14,7 k € | -60.9% | 37,4 k € | -90.8% | 406,5 k € |
| Debts | 7,6 M € | -10.1% | 8,5 M € | -0.3% | 8,5 M € | +3.8% | 8,2 M € | +74.0% | 4,7 M € |
| Other | |||||||||
| Workforce | 4,8 ETP | -2.0% | 4,9 ETP | -2.0% | 5,0 ETP | +31.6% | 3,8 ETP | -24.0% | 5,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 0 € and 100 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20253 active · 23 ended
Active mandates
Cédric VOLANTI
ActiveFranck BACKERS
ActiveJonas Skjødt MOLLER
ActiveEnded mandates
Other companies at this address
Avenue du Parc Industriel 89 4041 Herstal| Company | CBE no. |
|---|---|
Sartorius Xpress Biologics● Active | 0550.686.915 |
XpressBioX● Active | 0770.527.814 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/04/2026 | 09/04/2025 | 29/05/2024 | 26/05/2023 | 10/08/2022 | 12/04/2021 |
| General meeting | 26/03/2026 | 27/03/2025 | 16/05/2024 | 19/05/2023 | 25/03/2022 | 12/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 26/03/2026 | 13/04/2026 | French | |
| Abridged model | 31/12/2024 | 27/03/2025 | 09/04/2025 | French | |
| Abridged model | 31/12/2023 | 16/05/2024 | 29/05/2024 | French | |
| Abridged model | 31/12/2022 | 19/05/2023 | 26/05/2023 | French | |
| Abridged model | 31/12/2021 | 25/03/2022 | 10/08/2022 | French | |
| Abridged model | 31/12/2020 | 12/03/2021 | 12/04/2021 | French | |
| Abridged model | 31/12/2019 | 13/03/2020 | 24/06/2020 | French | |
| Abridged model | 31/12/2018 | 08/03/2019 | 19/03/2019 | French | |
| Abridged modelCorrection | 31/12/2017 | 09/03/2018 | 20/02/2019 | French | |
| Abridged model | 31/12/2017 | 09/03/2018 | 25/04/2018 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 0 € and 100 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 23 ended
Active mandates
Cédric VOLANTI
ActiveFranck BACKERS
ActiveJonas Skjødt MOLLER
ActiveEnded mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates28/01/2025DENOMINATION
- Mandates25/04/2024DEMISSIONS, NOMINATIONS
- Mandates11/04/2023DEMISSIONS, NOMINATIONS
- Mandates30/12/2022DEMISSIONS, NOMINATIONS
- Mandates30/09/2022DEMISSIONS, NOMINATIONS
- Mandates27/07/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Mandates19/07/2022DEMISSIONS, NOMINATIONS
- Capital / shares11/05/2022CAPITAL, ACTIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025167,7 k €↑
- 2024Annual accounts 202438,2 k €↑
- 2024Name changeSartorius Accessia Pharma
- 2023Annual accounts 2023-683,2 k €↑
- 2022Annual accounts 2022-1,1 M €↓
- 2021Annual accounts 2021-846,1 k €↓
- 2021Name changeACCESSIA PHARMA
- 2020Annual accounts 2020-825 k €↑
- 2019Annual accounts 2019-921,1 k €↑
- 2018Annual accounts 2018-1,2 M €↓
- 2017Annual accounts 2017-910,4 k €
- 22/03/2016IncorporationPublic limited company